Tower Research Capital (TRC)’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$670K Sell
11,810
-770
-6% -$48.5K 0.01% 1386
2026
Q2
$877K Sell
12,580
-1,843
-13% -$102K 0.02% 701
2026
Q1
$615K Buy
14,423
+9,646
+202% +$389K 0.02% 780
2025
Q4
$179K Sell
4,777
-888
-16% -$29.8K ﹤0.01% 1520
2025
Q3
$167K Sell
5,665
-7,106
-56% -$165K ﹤0.01% 1609
2025
Q2
$301K Buy
12,771
+11,186
+706% +$233K 0.01% 1417
2025
Q1
$28.7K Buy
1,585
+513
+48% +$10.1K ﹤0.01% 2654
2024
Q4
$18.3K Sell
1,072
-1,040
-49% -$18K ﹤0.01% 3262
2024
Q3
$31K Sell
2,112
-4,531
-68% -$56.8K ﹤0.01% 2986
2024
Q2
$75.5K Buy
6,643
+5,910
+806% +$64.5K ﹤0.01% 2787
2024
Q1
$7.97K Buy
+733
New +$7.33K ﹤0.01% 4103

Other funds holding BTSG

Tower Research Capital (TRC)'s BTSG Position: Q3 2026 in Review

Tower Research Capital (TRC) reduced its BrightSpring Health Services (BTSG) stake by 6.1% in Q3 2026, selling an estimated $48.5K and leaving 11,810 shares worth $670K. The position accounts for 0.01% of the portfolio, ranked #1386.

Tower Research Capital (TRC) first reported a position in BTSG in Q1 2024 and has held it in 11 quarters since. The position peaked at $877K in Q2 2026. 458 funds tracked by Wall St. Rank hold BTSG as of Q3 2026.

  • Tower Research Capital (TRC) held 11,810 shares of BrightSpring Health Services worth $670K as of Q3 2026.
  • Tower Research Capital (TRC) sold 770 BrightSpring Health Services shares in Q3 2026, an estimated $48.5K.
  • BrightSpring Health Services made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #1386 holding.
  • Tower Research Capital (TRC) first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 11 quarters since.
  • Tower Research Capital (TRC)'s BrightSpring Health Services position peaked at $877K in Q2 2026.
  • 458 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.